We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Computer System Launched To Manage Blood Screening Data

By LabMedica International staff writers
Posted on 21 Oct 2008
A computer system was launched that improves laboratory efficiency by managing test data when screening donated blood for hepatitis and retroviruses.

The new system will enable laboratories to track and trend quality control and performance of blood-screening assays and will provide laboratories with robust data capabilities through expanded archival features. It also will help blood-screening laboratories manage retesting of samples, produce reports, and generate statistical charts.

Called the Abbott Prism Director, the new system was launched by Abbott (Abbott Park, IL, USA) at the American Association of Blood Banks annual meeting on October 7, 2008, in Montreal, Canada. The Abbott Prism is an automated immunoassay analyzer designed to perform in vitro diagnostic donor screening for hepatitis and retroviruses. The analyzer is used by blood, plasma, organ, and tissue centers in more than 30 countries to screen more than 40 million donations each year.

"The worldwide launch of the Abbott Prism Director brings an important new product to our expanding portfolio of blood-screening systems and assays and demonstrates our continued commitment to blood-screening laboratories and the overall safety of the blood supply,” said James Stewart, Ph.D., director of research and development, Abbott Diagnostics. "For testing facilities that use multiple or single Abbott Prism instruments, the Abbott Prism Director offers data management functionality that can significantly enhance laboratory operations.”

Abbott is a global leader in in vitro diagnostics and provides a broad range of instrument systems and tests for hospitals, reference labs, molecular labs, blood banks, physician offices, and clinics. The company's diagnostic products offer customers automation, convenience, bedside testing, cost effectiveness, and flexibility.

Related Links:
Abbott


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated Biochemical Analyzer
iBC 900
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B

Latest Technology News

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation
21 Oct 2008  |   Technology

Ultra-Sensitive Biosensor Based on Light and AI Enables Early Cancer Diagnosis
21 Oct 2008  |   Technology

Low-Cost Biosensing Technology Detects Disease Biomarkers in Minutes
21 Oct 2008  |   Technology



PURITAN MEDICAL